Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome.


advertisement
Reply
 
Thread Tools Display Modes
Old 04-20-2009, 09:21 AM #1
Stitcher's Avatar
Stitcher Stitcher is offline
Magnate
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Stitcher Stitcher is offline
Magnate
Stitcher's Avatar
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Default Phytopharm: Commencement of Clinical Study of Cogane in Patients with PD

Phytopharm: Commencement of Clinical Study of Cogane in Patients with Parkinson's disease

http://www.pharmalive.com/News/index...&categoryid=21

GODMANCHESTER, Cambridgeshire, England, 20 April 2009, Phytopharm plc today announces the commencement of a safety, tolerability and pharmacokinetic (PK) study of its orally active neurotrophic factor inducer PYM50028 (Cogane•), which will involve both healthy volunteers and patients with Parkinson’s disease (PD). This follows approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Research Ethics Committee to commence recruitment for the UK study.
Stitcher is offline   Reply With QuoteReply With Quote

advertisement
Old 04-29-2009, 08:06 PM #2
Perryc Perryc is offline
Junior Member
 
Join Date: Aug 2006
Location: Washington DC
Posts: 77
15 yr Member
Perryc Perryc is offline
Junior Member
 
Join Date: Aug 2006
Location: Washington DC
Posts: 77
15 yr Member
Default Important study

This is an important study, for an oral neurothropic growth factor. Other nerve growth factors (GNDF, NTN) that have been tested since neuroimmunophilins failed in clinical trials, have required surgery to get the large molecules into the brain past the blood-brain barrier. and have used gene therapy approaches, which have the advantage of being one shot treatment, and the disadvantage of being one shot treatment,i.e no adjustments can be made after the viral vectors are implanted. Several of us met the President of Phytopharm at the BIO conference 2 years ago in Boston. He was beginning preclinical studies at that time, so its good that the study is finally starting.

Tom Isaacs has been working with the company from the patient perspective, so they are in good hands for patient inputs. Tom, if you see this post could you bring us up to date with respect to what development workhas been going on during the past 2 years.

What is the study design to prove safety and efficacy? Are they using any of the alternative methods such as Baysian conditional probabilities to build in learning from early steps into choices for next steps for efficient dose finding

What is the plan going forward for studies outside of UK, and particularly plans for FDA approval. When you get to the FDA, and we hope it is soon, please keep in mind the Pipeline Project expertise including FDA appointed pwp consultants, in putting patiets' interests first to help design effective trials, that balance the regulators needs for certainty with patients' willingness to take risks as long as there is transparency and full disclosure of what those risks are.

Perry


QUOTE=Stitcher;498601]Phytopharm: Commencement of Clinical Study of Cogane in Patients with Parkinson's disease

http://www.pharmalive.com/News/index...&categoryid=21

GODMANCHESTER, Cambridgeshire, England, 20 April 2009, Phytopharm plc today announces the commencement of a safety, tolerability and pharmacokinetic (PK) study of its orally active neurotrophic factor inducer PYM50028 (Cogane•), which will involve both healthy volunteers and patients with Parkinson’s disease (PD). This follows approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Research Ethics Committee to commence recruitment for the UK study.[/QUOTE]
Perryc is offline   Reply With QuoteReply With Quote
Old 05-01-2009, 09:29 AM #3
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
Default

Quote:
Originally Posted by Perryc View Post
This is an important study, for an oral neurothropic growth factor. Other nerve growth factors (GNDF, NTN) that have been tested since neuroimmunophilins failed in clinical trials, have required surgery to get the large molecules into the brain past the blood-brain barrier. and have used gene therapy approaches, which have the advantage of being one shot treatment, and the disadvantage of being one shot treatment,i.e no adjustments can be made after the viral vectors are implanted. Several of us met the President of Phytopharm at the BIO conference 2 years ago in Boston. He was beginning preclinical studies at that time, so its good that the study is finally starting.

Tom Isaacs has been working with the company from the patient perspective, so they are in good hands for patient inputs. Tom, if you see this post could you bring us up to date with respect to what development workhas been going on during the past 2 years.

What is the study design to prove safety and efficacy? Are they using any of the alternative methods such as Baysian conditional probabilities to build in learning from early steps into choices for next steps for efficient dose finding

What is the plan going forward for studies outside of UK, and particularly plans for FDA approval. When you get to the FDA, and we hope it is soon, please keep in mind the Pipeline Project expertise including FDA appointed pwp consultants, in putting patiets' interests first to help design effective trials, that balance the regulators needs for certainty with patients' willingness to take risks as long as there is transparency and full disclosure of what those risks are.

Perry


QUOTE=Stitcher;498601]Phytopharm: Commencement of Clinical Study of Cogane in Patients with Parkinson's disease

http://www.pharmalive.com/News/index...&categoryid=21

GODMANCHESTER, Cambridgeshire, England, 20 April 2009, Phytopharm plc today announces the commencement of a safety, tolerability and pharmacokinetic (PK) study of its orally active neurotrophic factor inducer PYM50028 (Cogane•), which will involve both healthy volunteers and patients with Parkinson’s disease (PD). This follows approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Research Ethics Committee to commence recruitment for the UK study.
[/QUOTE]


Perry,

I have applied to go on this trial and have received the application papers.

I am not sure how much can be disclosed publicly so I don't want to say too much. It is a 10 week trial and the purpose is stated as "to find out if Cogane is safe and well tolerated in both healthy volunteers and (PD) patients and to determine if there is any difference in the way that the body deals with Cogane between these two groups".

If I am accepted onto the trial then I will let you know and if you forward me any questions I will endeavor to get some answers if I am allowed.

Take care,
Neil.
aftermathman is offline   Reply With QuoteReply With Quote
Old 06-24-2009, 06:19 PM #4
JACKMANA JACKMANA is offline
Junior Member
 
Join Date: Apr 2007
Location: dx 4/04@55 WORCESTER, UK
Posts: 36
15 yr Member
JACKMANA JACKMANA is offline
Junior Member
 
Join Date: Apr 2007
Location: dx 4/04@55 WORCESTER, UK
Posts: 36
15 yr Member
Confused Cogane trial

Neil,
Did you complete the screening & if so were you accepted for the trial?
I was screened unsuccessfully & I still have no real understanding why. The whole process seemed very rushed - as though if you have Parkinson's you will have few commitments & can decamp at a moment's notice.
Yesterday I attended the launch of 'Healthtalk online' -clinical trials module as one who was filmed. This issue ie patients not getting sufficient information or feedback was raised in the presentation by professionals & by
clips from the site of different patients' experiences. As I see my future health resting on Cogane &/or similar treatments I was probably a lot more emotional about not meeting the (covert) criteria. I hope you can make sense of this feedback.
Angela.

Perry,

I have applied to go on this trial and have received the application papers.

I am not sure how much can be disclosed publicly so I don't want to say too much. It is a 10 week trial and the purpose is stated as "to find out if Cogane is safe and well tolerated in both healthy volunteers and (PD) patients and to determine if there is any difference in the way that the body deals with Cogane between these two groups".

If I am accepted onto the trial then I will let you know and if you forward me any questions I will endeavor to get some answers if I am allowed.

Take care,
Neil.[/QUOTE]
__________________
“Wisely and slow; they stumble that run fast." William Shakespeare
JACKMANA is offline   Reply With QuoteReply With Quote
Old 01-02-2011, 04:02 AM #5
indalo indalo is offline
New Member
 
Join Date: Dec 2010
Posts: 2
10 yr Member
indalo indalo is offline
New Member
 
Join Date: Dec 2010
Posts: 2
10 yr Member
Default

Hi how does one apply to be considered to take part in these trials?
I have heard a little about Cogane & it seems very interesting.
indalo is offline   Reply With QuoteReply With Quote
Old 01-06-2011, 06:37 PM #6
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
Default early stages?

We heard this trial was for those who are early on in the disease. please let me know if this is untrue...neil? or anyone who knows?

thanks,
paula
__________________
paula

"Time is not neutral for those who have pd or for those who will get it."
paula_w is offline   Reply With QuoteReply With Quote
Old 01-07-2011, 11:04 AM #7
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
Default Paula ...

Quote:
Originally Posted by paula_w View Post
We heard this trial was for those who are early on in the disease. please let me know if this is untrue...neil? or anyone who knows?

thanks,
paula
hope things are going well for you.

I never made it onto the trial, purely a matter of logistics, they had enough people apply who lived close to Cambridge so no hotel/travelling costs.

From memory this was not limited to early onset. I think it was minimum 5 years post dx with no maximum time limit. However like most trials they attempt to get the healthiest patients and exclude potential complications by excluding certain symptoms.

Tom Isaacs (CPT) is doing a lot of work with Cogane and is really high on it, (or was 18 months ago).

Take care,
Neil.
aftermathman is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
paula_w (01-07-2011)
Old 01-18-2011, 03:47 PM #8
jeanb's Avatar
jeanb jeanb is offline
Senior Member
 
Join Date: Aug 2006
Location: sonoran desert
Posts: 1,352
15 yr Member
jeanb jeanb is offline
Senior Member
jeanb's Avatar
 
Join Date: Aug 2006
Location: sonoran desert
Posts: 1,352
15 yr Member
Lightbulb de novo only

I contacted the study coordinator and was told that the trial in the States is for de novo pwp only.

Jean
__________________
Jean B

This isn't the life I wished for, but it is the life I have. So I'm doing my best.
jeanb is offline   Reply With QuoteReply With Quote
Old 04-13-2011, 05:41 AM #9
krugen68 krugen68 is offline
Member
 
Join Date: Oct 2010
Location: Surrey, England
Posts: 107
10 yr Member
krugen68 krugen68 is offline
Member
 
Join Date: Oct 2010
Location: Surrey, England
Posts: 107
10 yr Member
Default Cogane Trial II

Quote:
Originally Posted by jeanb View Post
I contacted the study coordinator and was told that the trial in the States is for de novo pwp only.

Jean
...I've got an assessment date in May for inclusion in the UK trial. You have to have taken no meds.....
Peter
__________________
Doctors are men who prescribe medicines of which they know little, to cure diseases of which they know less, in human beings of whom they know nothing”
Voltaire
krugen68 is offline   Reply With QuoteReply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Protecting patients human rights during clinical trials? lou_lou Parkinson's Disease 6 11-04-2018 12:30 PM
Patients' treatment in 2 different clinical trials jeanb Parkinson's Disease 2 08-02-2007 11:09 PM


All times are GMT -5. The time now is 02:52 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.